Market Overview:
The global MRI contrast agents market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of chronic diseases, rising demand for minimally invasive surgeries, and technological advancements in MRI contrast agents. Based on type, the global MRI contrast agents market is segmented into extracellular fluid agents, blood pool agents, and hepatobiliary (liver) agents. Extracellular fluid agent held the largest share of the global MRI contrast agent market in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to their high efficiency in detecting lesions and tumors located near tissues or organs that are not easily visible on an unenhanced scan image.
Product Definition:
MRI Contrast Agents are used to improve the visibility of organs or tissues in MRI scans. They work by altering the way that radio waves interact with tissue, making it easier to see certain features in a scan. Contrast agents can be used for a variety of purposes, including highlighting tumors, assessing damage after an injury, or evaluating blood flow.
Extracellular Fluid Agents:
Extracellular Fluid (ECF) agents, it's usage and growth factor in MRI contrast agents market is expected to grow at a significant rate over the forecast period. The increasing prevalence of neurological disorders such as multiple sclerosis, stroke, dementia among others coupled with rising demand for non-invasive diagnostic procedures are some major factors driving the ECF agents market.
Blood Pool Agents:
Blood pool agents are used in MRI contrast agents. They are also known as intravenous injection or IV drip agents. These contrast media contain gadolinium, which is an ionic compound that enhances the magnetic properties of the brain during an MRI scan.
The global blood pool agent.
Application Insights:
Based on application, the global MRI contrast agents market is segmented into hospitals and clinics. Hospitals held the largest share in 2017 owing to factors such as a large patient base with multiple imaging requirements, presence of dedicated diagnostic centers for various medical conditions, and availability of advanced healthcare facilities. Furthermore, an increase in hospital-based MRA due to technological advancements coupled with growing demand for faster imaging results is expected to drive growth over the forecast period.
Clinics are anticipated to witness significant growth during the forecast period owing to increasing utilization of MRIs by radiologists for evaluation of patients referred from primary care settings. Increasing awareness regarding cost-effective diagnosis along with rising income levels has led many people across developed nations undergo regular checkups at clinics where MRA procedures are performed frequently enough to support revenue growth at a steady rate during future years.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-developed healthcare infrastructure and high adoption rate for advanced diagnostic techniques are some factors responsible for its large share. Moreover, increasing demand to reduce waiting time and rising preference for ambulatory diagnostic centers are expected to drive regional growth during the forecast period.
Asia Pacific is expected to witness lucrative CAGR over the forecast period owing to improving healthcare facilities, growing medical tourism industry, and an increase in awareness about early diagnosis coupled with financial capability of patients. Furthermore, government initiatives such as “Hospital Efficient Management†program by Ministry of Health Labor & Welfare (Japan) aimed at reducing hospital stay from 2 days in 1 week to 1 day; thereby facilitating faster recovery time after surgery is anticipated boost regional MRI contrast agents market growth over the forecast period.
Growth Factors:
- Increasing incidence of cancer and other diseases that require diagnosis using MRI
- Growing demand for minimally invasive diagnostic procedures
- Rising healthcare expenditure by governments and private players
- Technological advancements in MRI contrast agents market
- Growing awareness about the benefits of MRI contrast agents
Scope Of The Report
Report Attributes
Report Details
Report Title
MRI Contrast Agents Market Research Report
By Type
Extracellular Fluid Agents, Blood Pool Agents, Hepatobiliary (Liver) Agents
By Application
Hospitals, Clinics
By Companies
Bayer, Bracco Imaging, Guerbet Group, Hengrui Medicine, Lantheus, YRPG, BeiLu Pharma, Bayer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
152
Number of Tables & Figures
107
Customization Available
Yes, the report can be customized as per your need.
Global MRI Contrast Agents Market Report Segments:
The global MRI Contrast Agents market is segmented on the basis of:
Types
Extracellular Fluid Agents, Blood Pool Agents, Hepatobiliary (Liver) Agents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer
- Bracco Imaging
- Guerbet Group
- Hengrui Medicine
- Lantheus
- YRPG
- BeiLu Pharma
- Bayer
Highlights of The MRI Contrast Agents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Extracellular Fluid Agents
- Blood Pool Agents
- Hepatobiliary (Liver) Agents
- By Application:
- Hospitals
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the MRI Contrast Agents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
MRI contrast agents are substances that help to improve the visibility of structures in an MRI scan. Contrast agents can be either water-based or oil-based and are injected into a vein before the MRI scan.
Some of the key players operating in the mri contrast agents market are Bayer, Bracco Imaging, Guerbet Group, Hengrui Medicine, Lantheus, YRPG, BeiLu Pharma, Bayer.
The mri contrast agents market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 MRI Contrast Agents Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 MRI Contrast Agents Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 MRI Contrast Agents Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the MRI Contrast Agents Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global MRI Contrast Agents Market Size & Forecast, 2020-2028
4.5.1 MRI Contrast Agents Market Size and Y-o-Y Growth
4.5.2 MRI Contrast Agents Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Extracellular Fluid Agents
5.2.2 Blood Pool Agents
5.2.3 Hepatobiliary (Liver) Agents
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global MRI Contrast Agents Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 MRI Contrast Agents Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Extracellular Fluid Agents
9.6.2 Blood Pool Agents
9.6.3 Hepatobiliary (Liver) Agents
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Extracellular Fluid Agents
10.6.2 Blood Pool Agents
10.6.3 Hepatobiliary (Liver) Agents
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Extracellular Fluid Agents
11.6.2 Blood Pool Agents
11.6.3 Hepatobiliary (Liver) Agents
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Extracellular Fluid Agents
12.6.2 Blood Pool Agents
12.6.3 Hepatobiliary (Liver) Agents
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Extracellular Fluid Agents
13.6.2 Blood Pool Agents
13.6.3 Hepatobiliary (Liver) Agents
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 MRI Contrast Agents Market: Competitive Dashboard
14.2 Global MRI Contrast Agents Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer
14.3.2 Bracco Imaging
14.3.3 Guerbet Group
14.3.4 Hengrui Medicine
14.3.5 Lantheus
14.3.6 YRPG
14.3.7 BeiLu Pharma
14.3.8 Bayer
